Stay Up
to Date
Stay Up
to Date
Breaking News,
Updates, & More
Breaking News,
Updates, & More
Click Here to
Subscribe
Click Here to
Subscribe

Web Exclusives

Most of the illnesses that are encountered in medicine are incurable. Diabetes and heart disease are 2 of the common, chronic, and incurable health conditions that require diligent monitoring.
The past decade has given us several breakthrough treatment options for a complex and serious malignancy, multiple myeloma (MM).

In the July issue, we published an article exploring the efforts to deal with the drug shortage issue. We asked our online reading community if they thought these regulatory and legislative actions would be effective.

  • 38% said they thought the recent actions would help resolve the issue
  • 62% indicated they were not confident that recent actions would be effective

Here’s a sample of the comments:

Multiple myeloma (MM) is the second most common hematologic malignancy in the United States.1,2 Approximately 21,700 new cases will be diagnosed in the United States during 2012 and 10,710 patients will die from this disease.

Drug Shortage Actions

Mediterranean White Bean and Lentil Salad

Ingredients

The US Food and Drug Administration (FDA) has approved a supplemental new drug application for Velcade (bor tezomib) for Injection (Millennium: The Takeda Oncology Company) that updates the label to include additional longterm (median follow-up 60.1 months) overall survival (OS) data from the VISTA trial. The VISTA trial examined the use of bortezomib-based therapy in patients with previously untreated multiple myeloma (MM).

Patients may not understand the information medical care providers give them for a number of reasons, but significant among them is poor healthcare literacy, which is the ability to understand health information and to use that information to make good decisions about health and medical care. Unfortunately, about 33% of the adult population in the United States has limited healthcare literacy. Yet, the need for this proficiency is greater than ever because medical care has become progressively more complex. Let us take a look at healthcare literacy facts and figures:

The development of venous thromboembolism (VTE) in patients with cancer has a significant impact in terms of morbidity and mortality and healthcare costs, according to a “real-world analysis” reported at the 2011 European Multidisciplinary Cancer Congress.

An investigational alpha-pharmaceutical not only prevented skeletal-related events (SREs) in patients with prostate cancer with bone metastases in a phase 3 study presented at the 2011 European Multidisciplinary Cancer Congress, but it also improved overall survival.

Page 26 of 32
Results 251 - 260 of 315